Novavax sees 2024 sales flat to lower, aims to pick up COVID vaccine market share
COVID-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as it works to improve its commercial performance and pick up market share from much larger rivals,...